Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Antibody-Drug-Conjugates (ADCs) are a real and increasingly important treatment class in multiple myeloma, with belantamab mafodotin as the leading example, but they are not standard therapy for solitary plasmacytoma. For plasmacytoma or extramedullary plasmacytoma, ADC use is mostly extrapolated from relapsed/refractory MM or supported by isolated case-level evidence rather than established disease-specific standards
…